Cargando…
Microbiome influencers of checkpoint blockade–associated toxicity
Immunotherapy has greatly improved cancer outcomes, yet variability in response and off-target tissue damage can occur with these treatments, including immune checkpoint inhibitors (ICIs). Multiple lines of evidence indicate the host microbiome influences ICI response and risk of immune-related adve...
Autores principales: | Wang, Yinghong, Jenq, Robert R., Wargo, Jennifer A., Watowich, Stephanie S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836236/ https://www.ncbi.nlm.nih.gov/pubmed/36622383 http://dx.doi.org/10.1084/jem.20220948 |
Ejemplares similares
-
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
por: Hayase, Eiko, et al.
Publicado: (2021) -
Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017) -
Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
por: Cooper, Zachary A, et al.
Publicado: (2014) -
Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022) -
Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
por: Dougan, Michael
Publicado: (2017)